People using continuous glucose monitoring devices must have access to blood glucose monitoring at all times. Cħ.6 People with diabetes should be provided with blood glucose monitoring devices as indicated by their circumstances, preferences, and treatment.
Eħ.5 Initiation of continuous glucose monitoring, continuous subcutaneous insulin infusion, and/or automated insulin delivery early in the treatment of diabetes can be beneficial depending on a person’s/caregiver’s needs and preferences. Eħ.4 Students must be supported at school in the use of diabetes technology including continuous subcutaneous insulin infusion, connected insulin pens, and automated insulin delivery systems as prescribed by their diabetes care team. Cħ.3 People who have been using continuous glucose monitoring, continuous subcutaneous insulin infusion, and/or automated insulin delivery for diabetes management should have continued access across third-party payers. Eħ.2 When prescribing a device, ensure that people with diabetes/caregivers receive initial and ongoing education and training, either in-person or remotely, and regular evaluation of technique, results, and their ability to use data, including uploading/sharing data (if applicable), to adjust therapy. In the setting of an individual whose diabetes is partially or wholly managed by someone else (e.g., a young child or a person with cognitive impairment), the caregiver’s skills and desires are integral to the decision-making process.
General Device Principlesħ.1 The type(s) and selection of devices should be individualized based on a person’s specific needs, desires, skill level, and availability of devices. Diabetes technology, when coupled with education and follow-up, can improve the lives and health of people with diabetes however, the complexity and rapid change of the diabetes technology landscape can also be a barrier to patient and provider implementation.
#WHERE DOES DIABETES PILOT STORE DATA SOFTWARE#
More recently, diabetes technology has expanded to include hybrid devices that both monitor glucose and deliver insulin, some automatically, as well as software that serves as a medical device, providing diabetes self-management support. Historically, diabetes technology has been divided into two main categories: insulin administered by syringe, pen, or pump (also called continuous subcutaneous insulin infusion ), and blood glucose as assessed by blood glucose monitoring (BGM) or continuous glucose monitoring (CGM). Diabetes technology is the term used to describe the hardware, devices, and software that people with diabetes use to help manage their condition, from lifestyle to blood glucose levels.
0 kommentar(er)
